Next Article in Journal
Harnessing Ionic Interactions and Hydrogen Bonding for Nucleophilic Fluorination
Previous Article in Journal
Use of Alginate Extracted from Moroccan Brown Algae to Stimulate Natural Defense in Date Palm Roots
Previous Article in Special Issue
Optimizing the Synthetic Route of Chromone-2-carboxylic Acids: A Step forward to Speed-up the Discovery of Chromone-based Multitarget-directed Ligands
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Microwave Assisted Reactions of Azaheterocycles Formedicinal Chemistry Applications

by
Dorina Amariucai-Mantu
1,
Violeta Mangalagiu
2,
Ramona Danac
1 and
Ionel I. Mangalagiu
1,2,*
1
Faculty of Chemistry, Alexandru Ioan Cuza University of Iasi, 11 Carol I, Iasi 700506, Romania
2
Institute of Interdisciplinary Research-CERNESIM Center, Alexandru Ioan Cuza University of Iasi, 11 Carol I, Iasi 700506, Romania
*
Author to whom correspondence should be addressed.
Molecules 2020, 25(3), 716; https://doi.org/10.3390/molecules25030716
Submission received: 9 January 2020 / Revised: 29 January 2020 / Accepted: 6 February 2020 / Published: 7 February 2020

Abstract

:
Microwave (MW) assisted reactions have became a powerful tool in azaheterocycles chemistry during the last decades. Five and six membered ring azaheterocycles are privileged scaffolds in modern medicinal chemistry possessing a large variety of biological activity. This review is focused on the recent relevant advances in the MW assisted reactions applied to azaheterocyclic derivatives and their medicinal chemistry applications from the last five years. The review is divided according to the main series of azaheterocycles, more precisely 5- and 6-membered ring azaheterocycles (with one, two, and more heteroatoms) and their fused analogues. In each case, the reaction pathways, the advantages of using MW, and considerations concerning biological activity of the obtained products were briefly presented.

Graphical Abstract

1. Introduction

Over the last three decades, microwave (MW) irradiation has become a successful tool applied in modern medicinal and organic chemistry. This is because MW have several crucial advantages comparative with conventional thermal heating (TH) such us: spectacular accelerations of chemical reactions, shorter reaction times, higher yields and higher product purities. Also, in many cases, under MW, the reactions become eco-friendly (having milder reaction conditions, suppressing side reactions, energy saving, using small amounts, or no organic solvents) [1,2,3,4,5,6,7,8,9,10]. In some cases described in the literature, reactions that did not occur under classical TH were only successful if carried out under MW [1,2,3,4].
The MW effects in chemical reactions rise up intense debates in the scientific community during the time. The effects was explained according with the MW mechanisms of action, while taking into considerations the contribution of electric field component of MW radiation, via three mechanisms: dipolar polarization mechanism, ionic conduction mechanism, and the non-thermal effects of highly polarizing radiation—the so called “specific effects of MW” [5,6,7,8,9,10]. Nowadays, it is almost unanimously accepted by scientists that the effects of MW in chemical reactions it is a complementarity of all of these three mechanisms, in different proportions, according with the environment of chemical reactions.
On the other hand, azaheterocycles are emerging as crucial privileged scaffolds in modern medicinal chemistry and drug discovery, a large variety of biological activities being described for these compounds, such as: antibacterial, antifungal, antitubercular, antiviral, antiplasmodial, antimalarial, anticancer, anti-inflammatory, antihypertensive, diuretics, antithrombics, anticoagulants, antidepressant, anxiolytics, anticonvulsant, analgesic, etc. [11,12,13,14,15].
In this review, we try to present an overview of the newest research in the microwave-assisted reactions applied to azaheterocyclic derivatives and their medicinal chemistry applications, from the literature reported during the last five years.

2. Syntheses and Biological Activities of Five- and Six-Membered Ring Azaheterocycles

2.1. Five Membered Ring Azaheterocycles

Five membered ring azaheterocycles, especially pyrroles, pyrazoles, imidazoles, triazoles, tetrazoles and their fused derivatives, are multitarget pharmacophores with a large variety of biological activities such as antibacterial, antifungal, antitubercular, antihelmintic, antiplasmodial, anticancer, anti-inflammatory, cardiotonic, antihypertensive, antithrombotic, antihistaminic, antiulcer, analgesic, neuroleptic, etc. [16,17,18,19,20,21,22,23,24]. Having these considerations in view, a lot of attention was paid by researchers for obtaining new compounds with such skeleton, using both conventional TH and MW technology.

2.1.1. Five Membered Ring Azaheterocycles with One and Two Heteroatoms

Alshareef et al. [25] synthesized different pyrrole derivatives, while using the MW assisted Friedländer cyclization method. When substituent Y was a cyano group, pyrrolopyridine derivatives 2ae were obtained, while when substituent Y was an ester or ketone group, pyrrolopyridine derivatives 2f and 2g were obtained. Under MW irradiation, the reactions have some consistent advantages, the reactions time substantially decreased (from hours to minutes) and the yields were 10–20% higher.
Molecules 25 00716 i001
A similar strategy was employed for the synthesis of pyrazolo-pyridine derivatives 4ae from the corresponding pyrazoles 3.
Molecules 25 00716 i002
The synthesized compounds were biologically evaluated by Ellman’s test on acetylcholinesterase inhibition, two of them (compounds 2b (98%) and 4a (96%)) having a potent inhibition of acetylcholinesterase if compared with the donepezil reference.
In their attempt to synthesize new antiviral compounds, Barradas et al. obtained two new classes of pyrrolo-thiazoles (7ad and 10ad) decorated with a carbohydrate moiety [26]. The syntheses suppose N-alkylations of thiazolederivatives 5 and 8, while using MW irradiation. It worth to point out that the reactions did not occur under conventional TH conditions.
Molecules 25 00716 i003
The obtained compounds were tested for their antiviral activity against Junín virus, with all compounds having a very good activity, but, unfortunately and a rather high toxicity.
As part of their research in the thiazoles derivatives series, Cagide et al. [27] synthesized new thiazole-chromene molecules type 13a,b and 14a,b, from 2-amino-thiazole 11a,b and chromone-2-carboxylic acid 12 via an amidation reactions. The synthesis was performed both under conventional TH and MW irradiation, and the comparative study TH versus MW revealed that the yields are roughly the same, but, under MW irradiation, the reactions time substantially decreased and the reagents used are cheaper. Thiazole derivatives have been identified as potent and selective ligands for adenosine receptor.
Molecules 25 00716 i004
In the pyrazoles derivatives series, Parmar et al. [28] obtained new chromeno-annulated thiopyrano-pyrazoles via an one-pot synthesis type domino-Knoevenagel–hetero-Diels–Alder reaction, using as starting material pyrazolothiones 15ac and O-alkenyloxy/alkynyloxy-salicylaldehydes/-naphthaldehydes 16ah and 17ah, respectively. Under conventional TH conditions, no matter the conditions they employed, no reaction took place. Using microwave irradiation, the reaction successfully occurred in good yields for the desired products (around 70%) and during a short reaction time (12–15 min).
Molecules 25 00716 i005
The synthesized compounds were tested for their antibacterial (six strains, Gram positive and Gram negative), antifungal (two strains) and antitubercular (Mycobacterium Tuberculosis H37RV) activities. Several compounds (18a, 18b, 18f, 18h, 19b, 19f, 20a, 20b, 21a) showed good antimicrobial activity (with MIC values in the range of 62.5–25 µg/mL).
Following their work to synthesize new anticancer derivatives, Kovács et al. [29] obtained a new type of steroids bearing an oxa-pyrazole moiety, 24ac and 25ac. For this purpose, they used the cyclocondensation reaction of 17β-N-acylhydrazones 22ac and 23ac, under both conventional TH and MW irradiation. While using MW irradiation, the reaction took place in a shorter reaction time and the yields of the products were increased.
Molecules 25 00716 i006
The obtained compounds were tested for their in vitro anticancer activity against four malignant cell lines (HeLa, MCF7, A2780, and A431), and most of them (especially 24 derivatives) exhibited a potent antineoplasic activity against HeLa cells, with one order of magnitude higher that the reference drug, cisplatin.
In the imidazoles series, Saikia et al. [30] synthesized new derivatives with nonsteroidal and steroidal skeleton from the epoxide 26, by a ring opening reaction while using azaheterocycles. The reaction took place under MW irradiation, the conventional TH being useless for these reactions. In the case of nonsteroidal epoxide 26, the ring opening of the epoxide is leading to imidazole derivatives 29ac and 30.
Molecules 25 00716 i007
The ring opening of the steroidal epoxide 31 is leading to imidazole derivatives 32ah.
Molecules 25 00716 i008
The antimicrobial activities of both imidazole derivatives with nonsteroidal and steroidal skeleton were determined, with compounds 32b and 32eg showing a moderate inhibition against bacteria (Escherichia coli, Pseudomonas syringae, Bacillus subtilis, Proteus vulgaris and Staphylococcus aureus).
While using MW irradiation, Sangi et al. [31] obtained several imidazolidines, oxazolidines, and benzoxazoles. As key intermediate in these reactions, they use 1,1-bis(thiomethyl)-2-nitroethylene 33, that treated with various alkyldiamines, hydroxylalkylamines, or hydroxylarylamines was leading to the desired compounds (34,35ae,36) in good yields and reduced reaction time (20 min).
Molecules 25 00716 i009
These compounds were tested as acetylcholinesterase (AChE) inhibitors by using an enzyme immobilized capillary reactor-tandem mass spectrometry. The benzoxazole derivative 35d showed the best inhibition profile.
In their attempt to obtain new antimalarial compounds, Kumar et al. [32] synthesized a series of new benzimidazole (38ac) and triazole (39ao) derivatives. The synthesis of triazoles derivatives 39ao took place under MW irradiation (using click chemistry), which allowed for good yields and reduced reaction time (20 min). The obtained benzimidazoles 38ac and triazoles 39ao were tested for their antimalarial activity against Plasmodium falciparum. Compounds 39a and 39h showed the highest antimalarial activity against that parasite, with IC50 values in the submicromolar range.
Molecules 25 00716 i010

2.1.2. Five Membered Ring Azaheterocycles with More Than Two Heteroatoms

During their research in the triazole series, Srinivas et al. [33] synthesized different 1,2,3-triazole derivatives type 42ag and 43ag, bearing a thiazolidinone moiety. The synthesis was achieved by the condensation reaction between 1,2,3-triazoles 41 with a primary aromatic amine and a thioglycolic acid and/orthiomalic acid. The reactions were conducted under conventional TH and MW irradiation, with the use of MW being more reliable: the reaction time substantially decreased (from 2–4 h to 5–10 min) and the yields were higher (with 10–20%).
Molecules 25 00716 i011
The obtained triazole derivatives 42ag and 43ag were evaluated for their anticancer activity on different cancer cell lines, together with a standard drug. Compound 43b had the best profile in terms of antiproliferative activity (IC50 in the micromolar range).
As part of their ongoing work in the azaheterocycles series with antimicrobial activity, Maračić et al. [34]. synthesized three different families of new hybrid 1,2,3-triazole decorated benzo fused heterocycles. For this purpose, they used click chemistry of several azides and the corresponding fused nitrogen heterocycles substituted with a triple bond. Thus, when they used benzoimidazoles and indoles 44ad, 1,2,3-triazolo-substituted benzimidazole and benzopyrroles 45as were obtained, respectively. 1,2,3-Triazolo-substituted benzothiazoles 47af were obtained when the benzothiazole 46 was used as propargylated starting compound. The reactions took place both under conventional TH and MW irradiation, the use of MW having the advantages of obtaining slightly higher yields of the products and a substantial decrease of the reaction time from 8 h to 30 min.
Molecules 25 00716 i012
The antibacterial activities against Gram-positive (Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes) and Gram-negative (Escherichia coli, Moraxella catarrhalis, Haemophilus influenzae) bacteria have been performed, benzimidazole–1,2,3-triazoles with a p-chlorophenyl and p-fluorophenyl linked to 4-position of the triazole having very good antibacterial activity, with an excellent result against M. catarrhalis (MICs 0.5–1 μg/mL).
Using click chemistry (from the corresponding coumarin azide (48, 50) and triple bond compounds), Kraljević et al. [35] obtained 4-substituted 1,2,3-triazole coumarins 49ap and 51af. The reaction took place under MW irradiation in good to very good yields (50 to 95%) and one hour reaction time.
Molecules 25 00716 i013
The obtained compounds were tested for their anticancer and antimicrobial activity. The anticancer activity was evaluated in different cancer cell lines, with compounds bearing a 5-iodoindolo moiety (51a, 51b) and benzimidazolo moiety (51d, 51f) having the highest anticancer activity (IC50 in the micromolar range). The antimicrobial activity was evaluated against Gram positive and Gram negative strains, three compounds showing high selectivity activity against Enterococcus species.
Akhtar et al. [36] prepared a new family of sulfonyl-piperidinyl-1,2,4-triazoles-thioacetamide 54ak by a relatively facile setup, via thioalkylation of sulfonyl-piperidinyl-1,2,4-triazoles-thiol 52 with activated N-substituted acetamides 53ak. The reactions were carried out under conventional TH and MW irradiation. Under MW, the setup procedure has some substantial advantages: the yields were higher with 20–40% and the reaction times dramatically decreased from hours (10–20 h) to 30–60 s.
Molecules 25 00716 i014
The obtained compounds were tested for their biological activity against carbonic anhydrase (bCA-II), acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) enzymes. Compound 48e showed very good activity against bCA-II (IC50 = 8.69 ± 0.38 µM), AChE (IC50 = 11.87 ± 0.19 µM), and BChE (IC50 = 26.01 ± 0.55 µM).
Komykhov et al. [37] synthesized a new class of fused 1,2,4-triazolo-pyrimidines 56ah as part of their effort to obtain new antimicrobial compounds. The reactions were conducted both under conventional TH and MW irradiation, with the use of MW having the advantage of not requiring catalyst.
Molecules 25 00716 i015
The obtained compounds were tested for their antibacterial and antifungal activity, having a moderate to low antibacterial activity, but significant antifungal activity (MIC between 12–50 µM).
Gomha et al. [38] synthesized a new class of triazolo-, tetrazolo-, imidazolo-, and pyrazolo- fused pyrimidines type 57af in their attempt to obtain new antidiabetic compounds.
Molecules 25 00716 i016
The synthesis was performed in good yields and short reaction time while using MW irradiation via one pot multicomponent reactions from the corresponding pyrazolone and azaheterocycle. The hypoglycemic activity of compounds was evaluated, with compounds 57a and 57c having a strong antidiabetic activity with IC50 values in nanomolar range.
Chandgude et al. [39] synthesized new tetrazole scaffolds type 58ag via one pot multicomponent reaction (an amine, a carboxylic acid derivative, an azide, and POCl3) while using MW irradiation. The synthesis has the advantages of being stereospecific, in a relatively good yield.
Molecules 25 00716 i017
The biological activity (for stroke attack prevention) of compounds was reported to be similar to the one of the marketed drug cilostazol.

2.2. Six Membered Ring Azaheterocycles

Six membered ring azaheterocycles are the most significant class of heterocycles used in medicinal chemistry, with these structures playing a key role in current medicinal therapy, many of them already being in use as drugs for humans [11,12]. Compounds containing pyridine, pyridazine, pyrimidine, pyrazine, -and their fused derivatives-, are described to possess a wide range of biological activities, with these including antiviral, anti-HIV, antituberculosis, antimalarial, antileishmanial, antibacterial, antifungal, anti-inflammatory, anticancer, antihypertensive, diuretics, antiaggregative, antiplatelet, cardiotonics, antineurodegenerative, antidepressant, anxiolytics, anticonvulsivant, analgesic, sedatives, antiallergic, etc. [16,21,40,41,42,43,44,45,46,47,48,49,50,51,52,53]. A large variety of syntheses are described for these compounds, with some of them using MW technology.

2.2.1. Six Membered Ring Azaheterocycles with One Heteroatom

While using MW irradiation, Bagley et al. [54] synthesized via cross-coupling Suzuki–Miyaura reactions, three different types of MK2 inhibitors (for treatment of Werner syndrome): quinolines 59ac, and pyrazoles 60 and 61.
Molecules 25 00716 i018
Under conventional TH, the reactions did not take place, while using MW irradiation the desired compounds are obtained in moderate yields. The biological effect of compounds is controversial, with the IC50 being roughly at the same level as the lethal dose.
Ajani et al. [55] synthesized a new class of quinolines (62al) bearing hydrazide-hydrazone moiety, while using MW assisted reactions, in continuation of their work in the field of antimicrobial derivatives. The reactions under MW allowed for them to obtain very good yields, high purity of compounds, and a very short reaction time (1–3 min).
Molecules 25 00716 i019
The antimicrobial activity was evaluated against Gram positive and Gram negative strains (six strains), with one compound 62e having an excellent nonselective antimicrobial activity, with an MIC value in the range of 3.13 to 0.39 μg/mL.
Zahra et al. [56] synthesized a new series of imidazoquinolone esters (63af and 64ad) and acids (65af and 66ad), via MW assisted cyclocondensation reactions of 7,8-diaminoquinolone and arene/heteroarenecarboxaldehydes. The uses of MW allow for excellent yields, high purity of compounds, and a short reaction time (8–10 min).
Molecules 25 00716 i020
The antimicrobial activity of imidazo-quinolone esters and acids were evaluated against bacteria (Gram positive and Gram negative) and fungi, with both classes of compounds having good antibacterial activity. Among the tested compounds, compounds 65e,f and 66c,d have excellent activity against two Gram-positive strains, Bacillus subtilis and Haemophilus influenzae.
Thangaraj et al. [57] synthesized a new series of quinolinederivatives 67ah under MW irradiation while using an Ugi one pot four component condensation of lipoic acid, cyclohexylisocyanide, aniline derivatives and 2-methoxy quinoline-3-carbaldehyde derivatives. The use of MW has the advantages of excellent yields, high purity of compounds, the use of inexpensive solvents, and a short reaction time (15 min).
Molecules 25 00716 i021
The synthesized compounds were evaluated for the in vitro antibacterial and antioxidant potency. The antimicrobial assay revealed that four quinolines (67b, 67c, 67g, and 67h) have a very good antimicrobialactivity against Bacillus cereus, Staphylococcus aureus, Escherichia coli, Enterococcus faecalis Candidaalbicans and Candida utilis. The study regarding the antioxidant properties revealed that three quinoline peptides (67b, 67g and 67h) are effective on DPPH scavenging agents.
Subashini et al. [58] synthesized new quinolyl-quinolinones compounds 68ah via a Friedlander reaction, under conventional TH and MW irradiation. Under MW irradiation, the reaction setups have the advantages of higher yields and purities of compounds, as well as shorter reaction time (from 7–9 h to 4–7 min).
Molecules 25 00716 i022
The obtained compounds were the subject of antimicrobial and antioxidant assay. The results showed that all of the compounds possess antibacterial activity (in good to moderate range) and are also potent as antioxidants (comparable to the standard ascorbic acid).
Mokaber–Esfahani et al. [59] obtained new pyrimidyl-quinolinones derivatives 69ag under conventional TH and MW irradiation. By comparison with conventional TH, the MW irradiation has the advantages of higher yields and shorter reaction time (from 4–8 h to 15–30 min).
Molecules 25 00716 i023
The antimicrobial activity was evaluated against Gram positive and Gram negative strains, with two compounds 69a and 69c having excellent antimicrobial activity, superior to reference drug ciprofloxacin.
Using MW irradiation and conventional TH, Shekarrao et al. [60] synthesized new fused pyridines 70ag, quinolines 71ac, pyrimidines 72ah, and quinazolines 73ac, with pyrazole skeleton. Under MW irradiation, the yields are higher and the reaction times decrease substantially (from 24 h to 15 min).
Molecules 25 00716 i024
Four of the synthesized fused azaheterocycles (pyridine 70a, quinoline 71c, pyrimidines 72a and 72d) showed excellent anticancer activity, which was comparable to reference drug doxorubicin.
In continuation of their seeking for new anticancer compounds, Cortés et al. [61] synthesized isoquinoline based derivatives 74ac, by conventional TH and MW irradiation, the last one having the advantages of higher yields, milder conditions, and shorter reaction time.
Molecules 25 00716 i025
The in vitro anticancer assay revealed that the isoquinoline derivatives 74ac possess very good activity against lung cancer and two breast cancer cell lines (IC50 values in the micromolar range).
De Nisco et al. [62] synthesized a series of pyridophenoxazinone isomers 75af and 75*af with antiproliferative activity, while using quinoline-5,8-dione and 2-aminophenols as starting materials. Under conventional TH, they only obtained trace of desired compounds 75af and 75*af, while the MW assisted reactions lead to the desired products in good yields.
Molecules 25 00716 i026
The pyridophenoxazinone isomers 75af and 75*af were found to exhibit good anticancer activity.

2.2.2. Six Membered Ring Azaheterocycles with Two and More Heteroatoms

Mantu et al. [63] developed a convenient, simple, and efficient synthesis of fused tetra- and penta-cyclic 1,2-diazines using MW and ultrasound (US) irradiation in continuation of their research in the field of biologically active compounds with 1,2-diazine skeleton. In this respect, they synthesized two new classes of fused pyridazine, tetracyclic benzoisoindolo-pyridazine 78ac and pentacyclic benzoisoindolo-phthalazine 79ac, from the corresponding pyridazine and phthalazine salts (76ac, 77ac) and 1,4-naphthoquinone, via a Huisgen 3 + 2 dipolar cycloaddition reaction. If compared with conventional TH, under MW and US irradiation, the products yields were higher (in some cases almost double), the reaction time is considerably reduced (from hours to minutes) and the consumed energy substantially decreased.
Molecules 25 00716 i027
The penta- and tetra-cyclic 1,2-diazines were evaluated for their in vitro anticancer activity. The pentacyclic 1,2-diazine derivatives exhibit significant anticancer activity against Breast Cancer MCF7, Leukemia MOLT-4, Leukemia CCRF-CEM, and Non-Small Cell Lung Cancer NCIH460. A feasible mechanisms of action for anticancer efficiency of the pentacyclic 1,2-diazines 79ac have been furnished.
In a comprehensive work, Zbancioc et al. [64] performed a thorough study concerning the preparation of 1,2-diazine with dihydroxyacetophenone skeleton and their antimicrobial and antitumoral activity. The synthesis of the desired pyridazine 81ae and phthalazine 82ae derivatives was performed under conventional TH and while using MW and US irradiation, by direct alkylation of nitrogen heterocycles with α-bromodihydroxyacetophenones 80ae. Under MW irradiation, the reaction time dramatically decreases (from 48 h to 5 min) and, in some cases, the yields were higher.
Molecules 25 00716 i028
The in vitro antimicrobial and anticancer assay reveals that compounds have a good potency in terms of antibacterial activity (against Gram-positive and Gram-negative strains) and moderate antifungal and anticancer activity (against HeLa cells).
Rehman et al. [65] synthesized new pyrimidines (83am) that were decorated with pyridine and sulfonamide moieties of potential interest in Alzheimer’s disease. The syntheses were carried out under conventional TH and MW irradiation. Under MW irradiation, the reaction time is reduced about five folds and the yields were slightly higher.
Molecules 25 00716 i029
The synthesized compounds were evaluated against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), because these enzymes play a crucial role in the treatment of Alzheimer’s disease. Compounds 83i and 83l were found to be the most active among this series (IC50 in the range of 3–5 μM).
Hosamani et al. [66] developed a simple and convenient method for synthesis of pyrimidine bearing a chromen-2-one moiety, under conventional TH and MW irradiation. By comparison with reaction under classical TH, under MW irradiation the yields were higher (with about 20–25%) and the reaction time substantially decreased, from about 800 to 15 min.
Molecules 25 00716 i030
The in vitro anticancer assay (on human lung carcinomaA-549 and human adenocarcinoma mammary glandMDA-MB-231) reveals that the obtained compounds have significant anticancer activity, with two of compounds 83b and 83j being superior to the standard drug Cisplatin.
Kaoukabi et al. [67] synthesized two new classes of pyrimidine derivatives 86af and 87al with antiviral activity, while using both conventional TH and MW irradiation. The advantages of using MW are better yields (increased with about 50%) and smaller reaction times (times decreased from hours to minutes).
Molecules 25 00716 i031aMolecules 25 00716 i031b
The obtained compounds were evaluated for their antiviral activity, with four of the tested compounds (87c, d, f, g) having a substantial activity, with an EC50 in the range of 3–10 μM.
Khaldi-Khellafi et al. [68] synthesized new pyrimidine derivatives 88an analogs of curcumin in their attempt to obtain compounds with antioxidant and antibacterial activity. The synthesis was performed by MW irradiation and conventional TH. Under MW irradiation, the reaction time decreased substantially from 6–9 h to 3–5 min and the yields were roughly the same in both methods.
Molecules 25 00716 i032
The biological activity data of the synthesized compounds showed that most of them exhibited greater antioxidant and antibacterial activity than the standard drug curcumin.
Bhatia et al. [69] synthesized a new class of bis-pyrimidine derivatives 89aj with antibacterial activity. The synthesis was performed by MW irradiation and conventional TH. Under MW irradiation, the yields were higher, with about 10–15%, and the reaction time decreased substantially from 6–15 h to 10–15 min.
Molecules 25 00716 i033
The obtained compounds were screened for their antimicrobial activity against Gram-positive and Gram-negative strains and several fungi. The obtained results reveal that compounds with electron-donating substituent (Y) on the phenyl ring have remarkable antibacterial activity, while compounds having electron-withdrawing substituent exhibited excellent antifungal activity.
In a subsequent paper, Bhatia et al. [70] synthesized another series of bis-pyrimidine derivatives 90aj with antibacterial activity. The synthesis was performed again by MW irradiation and conventional TH, under MW irradiation the yields being higher, the reaction time decreased and the work-up conditions were milder.
Molecules 25 00716 i034
The in vitro antimicrobial assay (Gram-positive and Gram-negative strains, fungi) revealed that compounds 90 showed good antibacterial and antifungal activities. However, compound 90j was the most active in terms of antibacterial potency, while compound 90b was the most potent in terms of antifungal properties.
Sompalle et al. [71] synthesized a new class of fused triazoloquinazoline derivatives 91ao, while using MW irradiation and conventional TH. No matter the conditions were employed, under conventional TH, the reactions did not take place, while, under MW irradiation, the compounds were obtained in good yields and short period of time (~3 min). The compounds were tested for their antioxidant activity, all presenting a moderate activity.
Molecules 25 00716 i035
Following their goal to obtain new adenosine receptor (AR) antagonists, Burbiel et al. [72] synthesized several classes of triazoloquinazolines 9495. In this respect, in the first step, 2-aminobenzonitrile was treated with the appropriate acyl halides and then in the second step with hydrazine hydrate, when quinazoline derivatives 92am were obtained. The reactions were performed under both MW irradiation and conventional TH. In the case of aliphatic acyl halides, the un-cyclized intermediates 93am were obtained, but the separation of this intermediate was not necessary, because both of the isomers lead to the same triazoloquinazolines 94am and 95ac derivatives in the subsequent condensation step with all different employed reagents. Under MW irradiation, the reaction time substantially decreased from 5–24 h to 10–20 min and the yields were slightly higher.
Molecules 25 00716 i036
The affinity of obtained compounds as AR antagonists was tested. In many cases, significantly different affinities for human and rat receptors were observed, with low nanomolar Ki values.

3. Concluding Remarks

No doubt, by comparison with conventional TH, microwave assisted reactions offer several crucial advantages, such as spectacular accelerations of chemical reactions, shorter reaction times, higher yields and higher product purities, eco-friendly synthesis, and reactions that only occur under MW irradiation. As a result, MW assisted reactions remain a useful and an alternative tool for conventional TH in modern medicinal chemistry.

Author Contributions

Design and conception was performed by I.I.M. I.I.M., D.A.-M., V.M. and R.D. contribute by writing, reviewing and approving the final version. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

Authors are thankful to Romanian Ministry of Research and Innovation, Program 1- Development of the national R & D system, Subprogram 1.2—Institutional performance—RDI excellence financing projects, Grant no. 34PFE, for financial support and the POSCCE-O 2.2.1, SMIS-CSNR 13984-901, No. 257/28.09.2010 Project, CERNESIM, for NMR experiments.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Cravotto, G.; Carnaroglio, D. (Eds.) Microwave Chemistry; De Gruyter: Berlin, Germany; Boston, MA, USA, 2017; ISBN 9873110479928. [Google Scholar]
  2. Loupy, A. (Ed.) Microwaves in Organic Synthesis, 2nd ed.; Wiley-VCH: Weinheim, Germany, 2006; ISBN 9783527314522. [Google Scholar]
  3. Van der Eycken, E.; Kappe, C.O. (Eds.) Microwave-Assisted Synthesis of Heterocycle; Springer: Berlin/Heidelberg, Germany, 2006; ISBN 9783540309833. [Google Scholar]
  4. Microwaves in Organic and Medicinal Chemistry; Kappe, O.C.; Stadler, A. (Eds.) Wiley-VCH: Weinheim, Germany, 2005; ISBN 9783527606831. [Google Scholar]
  5. Zbancioc, G.; Moldoveanu, C.; Zbancioc, A.M.; Humelnicu, I.; Mangalagiu, I.I. New inside concerning microwave mechanism in cycloaddition reactions: Thermal heating versus specific effects of microwave. Rev. Roum. Chim. 2016, 61, 441–444. [Google Scholar]
  6. Zbancioc, G.; Moldoveanu, C.; Zbancioc, A.M.; Mangalagiu, I.I. Microwave Assisted Synthesis of New Pyrrolopyridazine Derivatives with Acetophenone Skeleton. Part V. Curr. Microw. Chem. 2014, 1, 41–46. [Google Scholar] [CrossRef]
  7. Zbancioc, G.; Bejan, V.; Risca, M.; Moldoveanu, C.; Mangalagiu, I.I. Microwave assisted reactions of new azaheterocyles compounds. Molecules 2009, 14, 403–411. [Google Scholar] [CrossRef] [Green Version]
  8. De La Hoz, A.; Diaz-Ortiz, A.; Moreno, A. Microwaves in organic synthesis. Thermal and non-thermal microwave effects. Chem. Soc. Rev. 2005, 34, 164–178. [Google Scholar] [CrossRef]
  9. Kappe, O.C. Controlled microwave heating in modern organic synthesis. Angew. Chem. Int. Ed. 2004, 43, 6248–6250. [Google Scholar] [CrossRef]
  10. Lidström, P.; Tierney, J.; Wathey, B.; Westman, J. Microwave assisted organic synthesis-A review. Tetrahedron 2001, 57, 9225–9283. [Google Scholar] [CrossRef]
  11. Brunton, L.; Knollmann, B.; Hilal-Dandan, R. Goodman & Gilman’s the Pharnacologicalbassis of Therapeutics, 13th ed.; McGraw-Hill: New York, NY, USA, 2013; ISBN 13 9781259584732. [Google Scholar]
  12. Pozharskii, A.F.; Soldatenkov, A.T.; Katritzky, A.R. Heterocycles in Life and Society—An Introduction to Heterocyclic Chemistry, Biochemistry and Applications; Wiley-VCH: Weinheim, Germany, 2011; ISBN 978-0-470-71411-9. [Google Scholar]
  13. Neha, D.A.R.; Kumar, R.; Kumar, V. Recent synthetic strategies for monocyclic azole nucleus and its role in drug discovery and development. Curr. Org. Synth. 2018, 15, 321–340. [Google Scholar] [CrossRef]
  14. Chourasiya, S.S.; Kathuria, D.; Wani, A.A.; Bharatam, P.V. Azines: Synthesis, structure, electronic structure and their applications. Org. Biomol. Chem. 2019, 17, 8486–8521. [Google Scholar] [CrossRef]
  15. Kalaria, P.N.; Karad, S.C.; Raval, D.K.A. A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery. Eur. J. Med. Chem. 2018, 158, 917–936. [Google Scholar] [CrossRef] [PubMed]
  16. Al Matarneh, C.M.; Shova, S.; Mangalagiu, I.I.; Danac, R. Synthesis, structure, antimycobacterial and anticancer evaluation of new pyrrolo-(phenanthroline) derivatives. J. Enzym. Inhib. Med. Chem. 2016, 31, 470–480. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Thanikachalam, P.V.; Maurya, R.K.; Garg, V.; Monga, V. An insight into the medicinal perspective of synthetic analogs of indole: A review. Eur. J. Med. Chem. 2019, 180, 562–612. [Google Scholar] [CrossRef] [PubMed]
  18. Danac, R.; Al Matarneh, C.M.; Shova, S.; Daniloaia, T.; Balan, M.; Mangalagiu, I.I. New indolizines with phenanthroline skeleton: Synthesis, structure, antimycobacterial and anticancer evaluation. Bioorg. Med. Chem. 2015, 23, 2318–2327. [Google Scholar] [CrossRef] [PubMed]
  19. Naim, M.J.; Alam, O.; Nawaz, F.; Alam, M.J.; Alam, P. Current status of pyrazole and its biological activities. J. Pharm. Bioall. Sci. 2016, 8, 2–17. [Google Scholar]
  20. Ali, I.; Lone, M.N.; Aboul-Enein, H.Y. Imidazoles as potential anticancer agents. MedChemComm 2017, 8, 1742–1773. [Google Scholar] [CrossRef]
  21. Mantu, D.; Antoci, V.; Moldoveanu, C.; Zbancioc, G.; Mangalagiu, I.I. Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of theiranticancer and antimycobacterialactivity. J. Enzym. Inhib. Med. Chem. 2016, 31, 96–103. [Google Scholar] [CrossRef] [Green Version]
  22. Bansal, Y.; Silakari, O. The therapeutic journey of benzimidazoles: A review. Bioorg. Med. Chem. 2012, 20, 6208–6236. [Google Scholar] [CrossRef]
  23. Bozorov, K.; Zhao, J.; Aisa, H.A. 1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview. Bioorg. Med. Chem. 2019, 27, 3511–3531. [Google Scholar] [CrossRef]
  24. Kaushik, N.; Kumar, N.; Kumar, A.; Singh, U.K. Tetrazoles: Synthesis and biological activity. Immun. Endoc. Metab. Agents Med. Chem. 2018, 18, 3–21. [Google Scholar] [CrossRef]
  25. Alshareef, H.F.; Mohamed, H.A.E.H.; Salaheldin, A.M. Synthesis and biological evaluation of new tacrine analogues under microwave irradiation. Chem. Pharm. Bull. 2017, 65, 732–738. [Google Scholar] [CrossRef] [Green Version]
  26. Barradas, J.S.; Errea, M.I.; Sepúlveda, C.; Damonte, E.B.; D’Accorso, N.B. Microwave-assisted synthesis of pyrrolo[2,1-b]thiazoles linked to a carbohydrate moiety. J. Heterocycl. Chem. 2014, 51, 96–100. [Google Scholar] [CrossRef]
  27. Cagide, F.; Borges, F.; Gomes, L.R.; Low, J.N. Synthesis and characterisation of new 4-oxo-N-(substituted-thiazol-2-yl)-4H-chromene-2-carboxamides as potential adenosine receptor ligands. J. Mol. Struct. 2015, 1089, 206–215. [Google Scholar] [CrossRef]
  28. Parmar, B.D.; Sutariya, T.R.; Brahmbhatt, G.C.; Sharma, M.K.; Yadav, M.R. One-pot synthesis, biological evaluation, and docking study of new chromeno-annulated thiopyrano[2,3-c]pyrazoles. Mol. Divers. 2016, 20, 639–657. [Google Scholar] [CrossRef] [PubMed]
  29. Kovács, D.; Mótyán, G.; Wölfling, J.; Zupkó, I.; Frank, É. A facile access to novel steroidal 17-2′-(1′,3′,4′) -oxadiazoles, and an evaluation of their cytotoxic activities in vitro. Bioorg. Med. Chem. Lett. 2014, 24, 1265–1268. [Google Scholar] [CrossRef] [PubMed]
  30. Saikia, P.; Kaishap, P.P.; Goswami, J.; Gogoi, S.; Boruah, R.C. Synthesis of steroidal and nonsteroidal vicinal heterocyclic alcohols, N-(1-cycloalkenyl)heterocycles and their antibacterial studies. Steroids 2014, 84, 36–45. [Google Scholar] [CrossRef] [PubMed]
  31. Sangi, D.P.; Monteiro, J.L.; Vanzolini, K.L.; Paixão, M.W.; Corrêa, A.G. Microwave-assisted synthesis of N-heterocycles and their evaluation using an acetylcholinesterase immobilized capillary reactor. J. Braz. Chem. Soc. 2014, 25, 887–889. [Google Scholar] [CrossRef]
  32. Kumar, P.; Achieng, A.O.; Rajendran, V.; Kempaiah, P.; Rathi, B. Synergistic blending of high-valued heterocycles inhibits growth of Plasmodium falciparum in culture and P. berghei infection in mouse model. Sci. Rep. 2017, 7, 6724. [Google Scholar] [CrossRef] [PubMed]
  33. Srinivas, A.; Sunitha, M.; Raju, K.; Nikitha, G.; Govind Rao, C. Microwave-assisted synthesis of hybrid heterocycles as potential anticancer agents. Actachim. Slov. 2017, 64, 319–331. [Google Scholar] [CrossRef] [Green Version]
  34. Maračić, S.; Kraljević, T.G.; Paljetak, H.Č.; Cetina, M.; Raić-Malić, S. 1,2,3-Triazole pharmacophore-based benzofused nitrogen/sulfur heterocycles with potential anti-Moraxella catarrhalis activity. Bioorg. Med. Chem. 2015, 23, 7448–7463. [Google Scholar] [CrossRef]
  35. Kraljević, T.G.; Harej, A.; Sedić, M.; Talapko, J.; Raić-Malić, S. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole–coumarin hybrids. Eur. J. Med. Chem. 2016, 124, 794–808. [Google Scholar] [CrossRef]
  36. Akhtar Virk, N.; Rehman, A.; AtharAbbasi, M.; Siddiqui, S.Z.; Rashid, U.; Iqbal, J.; Saleem, M.; Ashraf, M.; Shahid, W.; Ali Shah, S.A. Conventional versus microwave assisted synthesis, molecular dockingand enzyme inhibitory activities of new 3,4,5-trisubstituted-1,2,4-triazole analogues. Pak. J. Pharm. Sci. 2018, 31, 1501–1510. [Google Scholar]
  37. Komykhov, S.A.; Tkachenko, I.G.; Musatov, V.I.; Chebanov, V.A.; Desenko, S.M. Multicomponent synthesis in water of 7-unsubstituted 4,7-dihydro-1,2,4-triazolo[1,5-a]pyrimidines and their antimicrobial and antifungal activity. Arkivoc 2016, IV, 277–287. [Google Scholar]
  38. Gomha, S.M.; Eldebss, T.M.A.; Badrey, M.G.; Abdulla, M.M.; Mayhoub, A.S. Novel 4-Heteroaryl-Antipyrines as DPP-IV Inhibitors. Chem. Biol. Drug Des. 2015, 86, 1292–1303. [Google Scholar] [CrossRef]
  39. Chandgude, A.L.; Dömling, A. Convergent Three-Component Tetrazole Synthesis. Eur. J. Org. Chem. 2016, 2016, 2383–2387. [Google Scholar] [CrossRef]
  40. Kishbaugh, T.L.S. Pyridines and Imidazopyridines with medicinal significance. Curr. Top. Med. Chem. 2016, 16, 3274–3302. [Google Scholar] [CrossRef]
  41. Kumari, L.S.; Mazumder, A.; Kumar, V.; Gupta, S. Synthesis and biological potentials of quinoline analogues: A review of literature. Mini-Rev. Org. Chem. 2019, 16, 653–688. [Google Scholar] [CrossRef]
  42. Olaru, A.M.; Vasilache, V.; Danac, R.; Mangalagiu, I.I. Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII. J. Enzym. Inhib. Med. Chem. 2017, 32, 1291–1298. [Google Scholar] [CrossRef] [Green Version]
  43. Wojcicka, A.; Nowicka-Zuchowska, A. Synthesis and biological activity of pyridopyridazine derivatives: A mini review. Mini-Rev. Org. Chem. 2019, 16, 3–11. [Google Scholar] [CrossRef]
  44. Popovici, L.; Amarandi, R.M.; Mangalagiu, I.I.; Mangalagiu, V.; Danac, R. Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives. J. Enzym. Inhib. Med. Chem. 2019, 34, 230–243. [Google Scholar] [CrossRef] [Green Version]
  45. Mantu, D.; Luca, M.C.; Moldoveanu, C.; Zbancioc, G.; Mangalagiu, I.I. Synthesis and antituberculosis activity of some new pyridazine derivatives. Part II. Eur. J. Med. Chem. 2010, 45, 5164–5168. [Google Scholar] [CrossRef]
  46. Butnariu, R.; Mangalagiu, I.I. New pyridazine derivatives: Synthesis, chemistry and biological activity. Bioorg. Med. Chem. 2009, 17, 2823–2829. [Google Scholar] [CrossRef]
  47. Sangshetti, J.; Pathan, S.K.; Patil, R.; Arote, R.; Shinde, D.B. Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review. Bioorg. Med. Chem. 2019, 27, 3979–3997. [Google Scholar] [CrossRef] [PubMed]
  48. Kumar, S.; Narasimhan, B. Therapeutic potential of heterocyclic pyrimidine scaffolds. Chem. Cent. J. 2018, 12, 38. [Google Scholar] [CrossRef] [PubMed]
  49. Jubete, G.; De La Bellacasa, R.P.; Estrada-Tejedor, R.; Teixidó, J.; Borrell, J.I. Pyrido[2,3-d]pyrimidin-7(8H)-ones: Synthesis and biomedical applications. Molecules 2019, 24, 4161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Goel, R.; Luxami, V.; Paul, K. Recent advances in development of imidazo[1,2-a]pyrazines: Synthesis, reactivity and their biological applications. Org. Biomol. Chem. 2015, 13, 3525–3555. [Google Scholar] [CrossRef] [PubMed]
  51. Kaushal, T.; Srivastava, G.; Sharma, A.; Singh Negi, A. An insight into medicinal chemistry of anticancer quinoxalines. Bioorg. Med. Chem. 2019, 27, 16–35. [Google Scholar] [CrossRef] [PubMed]
  52. Carmona-Martínez, V.; Ruiz-Alcaraz, A.J.; Vera, M.; Martínez-Esparza, M.; García-Peñarrubia, P. Therapeutic potential of pteridine derivatives: A comprehensive review. Med. Res. Rev. 2019, 39, 461–516. [Google Scholar] [CrossRef] [PubMed]
  53. Vila, N.; Besada, P.; Viña, D.; Sturlese, M.; Moro, S.; Terán, C. Synthesis, biological evaluation and molecular modeling studies of phthalazin-1(2H)-one derivatives as novel cholinesterase inhibitor. RSC Adv. 2016, 6, 46170–46185. [Google Scholar] [CrossRef]
  54. Bagley, M.C.; Baashen, M.; Chuckowree, I.; Dwyer, J.; Kipling, D.; Davis, T. Microwave-Assisted Synthesis of a MK2 Inhibitor by Suzuki-Miyaura Coupling for Study in Werner Syndrome Cells. Pharmaceuticals 2015, 8, 257–276. [Google Scholar] [CrossRef]
  55. Ajani, O.O.; Iyaye, K.T.; Audu, O.Y.; Kuye, A.O.; Olanrewaju, I.O. Microwave Assisted Synthesis and Antimicrobial Potential of Quinoline-Based 4-Hydrazide-Hydrazone Derivatives. J. Heterocycl. Chem. 2018, 55, 302–312. [Google Scholar] [CrossRef] [Green Version]
  56. Zahra, J.A.; Al-Qawasmeh, R.A.; El-Abadelah, M.M.; Abadleh, M.M.; Zani, F.; Incerti, M.; Vicini, P.; Voelter, W. Heterocycles [h]-fused to 4-oxoquinoline-3-carboxylic acid. Part XI: Synthesis and antibacterial activity of 4-fluoro-6-Oxoimidazo[4,5-h]quinoline-7-carboxylic acids. Z. Nat.-B 2016, 71, 37–44. [Google Scholar] [CrossRef]
  57. Thangaraj, M.; Gengan, R.M.; Ranjan, B.; Muthusamy, R. Synthesis, molecular docking, antimicrobial, antioxidant and toxicity assessment ofquinoline peptides. J. Photochem. Photobiol.-B 2018, 178, 287–295. [Google Scholar] [CrossRef] [PubMed]
  58. Subashini, R.; Angajala, G.; Aggile, K.; Nawaz Khan, F. Microwave-assisted solid acid-catalyzed synthesis of quinolinylquinolinones and evaluation of their antibacterial, antioxidant activities. Res. Chem. Intermed. 2015, 41, 4899–4912. [Google Scholar] [CrossRef]
  59. Mokaber-Esfahani, M.; Eshghi, H.; Akbarzadeh, M.; Hakimi, M.; Lari, J. Synthesis and Antibacterial Evaluation of New Pyrimidyl N-Ciprofloxacin Derivatives. Chem. Sel. 2019, 4, 8930–8933. [Google Scholar] [CrossRef]
  60. Shekarrao, K.; Kaishap, P.P.; Saddanapu, V.; Gogoi, S.; Boruah, R.C. Microwave-assisted palladium mediated efficient synthesis of pyrazolo[3,4-b]pyridines, pyrazolo[3,4-b]quinolines, pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]quinazolines. RSC Adv. 2014, 4, 24001–24006. [Google Scholar] [CrossRef]
  61. Cortés, I.; BoriniEtichetti, C.M.; Girardini, J.E.; Kaufman, T.S.; Bracca, A.B.J. Total Synthesis and Cytotoxic Activity of 6,8-Dimethoxy-1,3-dimethylisoquinoline Isolated from Ancistrocladustectorius: A 6π-Azaelectrocyclization Approach. Synthesis 2019, 51, 433–440. [Google Scholar]
  62. De Nisco, M.; Bolognese, A.; Sala, M.; Pedatella, S.; Manfra, M. Microwave-Assisted Synthesis of Pyridophenoxazinones, a Class of Antiproliferative Compounds. ChemistrySelect 2016, 1, 1292–1295. [Google Scholar] [CrossRef]
  63. Mantu, D.; Maftei, D.; Iurea, D.; Ursu, C.; Bejan, V. Synthesis, structure, and in vitro anticancer activity of new polycyclic 1,2-diazines. Med. Chem. Res. 2014, 23, 2909–2915. [Google Scholar] [CrossRef]
  64. Balan, A.M.; Miron, A.; Tuchilus, C.; Rotinberg, P.; Mihai, C.T.; Mangalagiu, I.I.; Zbancioc, G. Syntheses, antimicrobial and antitumoral activity of some novel dihydroxyacetophenone derivatives. Med. Chem. 2014, 10, 476–483. [Google Scholar]
  65. Rehman, T.U.; Khan, I.U.; Ashraf, M.; Riaz, S.; Yar, M. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer’s Disease. Arch. Pharm. 2017, 350, 1600304. [Google Scholar] [CrossRef]
  66. Hosamani, K.M.; Reddy, D.S.; Devarajegowda, H.C. Microwave-assisted synthesis of new fluorinated coumarin–pyrimidine hybrids as potent anticancer agents, their DNA cleavage and X-ray crystal studies. RSC Adv. 2015, 5, 11261–11271. [Google Scholar] [CrossRef]
  67. Kaoukabi, H.; Kabri, Y.; Curti, C.; Taourirte, M.; Rodriguez-Ubis, J.C.; Snoeck, R.; Andrei, G.; Vanelle, P.; Lazrek, H.B. Dihydropyrimidinone/1,2,3-triazole hybrid molecules: Synthesis and anti-varicella-zoster virus (VZV) evaluation. Eur. J. Org. Chem. 2018, 155, 772–781. [Google Scholar] [CrossRef] [PubMed]
  68. Khaldi-Khellafi, N.; Makhloufi-Chebli, M.; Oukacha-Hikem, D.; Benazzouz-Touami, A.; Dumas, F. Green synthesis, antioxidant and antibacterial activities of 4-aryl-3,4-dihydropyrimidinones/thiones derivatives of curcumin. Theoretical calculations and mechanism study. J. Mol. Struct. 2019, 1181, 261–269. [Google Scholar] [CrossRef]
  69. Bhatia, S.K.; Samdhian, V.; Kaur, B. Bis-dihydropyrimidines: Catalyst-free, Microwave-assisted Organic Synthesis, Characterization and In Vitro Biological Screenings. J. Heterocycl. Chem. 2018, 55, 935–942. [Google Scholar] [CrossRef]
  70. Bhatia, S.K.; Samdhian, V.; Kaur, B. Eco-friendly synthesis of solid-support bis-dihydropyrimidinesand their antimicrobial studies. Asian J. Chem. 2019, 31, 1489–1494. [Google Scholar] [CrossRef]
  71. Sompalle, R.; Roopan, S.M. Microwave assisted synthesis of ring junction heterocyclic antioxidants. Res. Chem. Intermed. 2016, 42, 5353–5366. [Google Scholar] [CrossRef]
  72. Burbiel, J.C.; Ghattas, W.; Küppers, P.; Hockemeyer, J.; Müller, C.E. 2-Amino[1,2,4]triazolo[1,5-c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure–Activity Relationships of Potent Adenosine Receptor Antagonists. ChemMedChem 2016, 11, 2272–2286. [Google Scholar] [CrossRef]

Share and Cite

MDPI and ACS Style

Amariucai-Mantu, D.; Mangalagiu, V.; Danac, R.; Mangalagiu, I.I. Microwave Assisted Reactions of Azaheterocycles Formedicinal Chemistry Applications. Molecules 2020, 25, 716. https://doi.org/10.3390/molecules25030716

AMA Style

Amariucai-Mantu D, Mangalagiu V, Danac R, Mangalagiu II. Microwave Assisted Reactions of Azaheterocycles Formedicinal Chemistry Applications. Molecules. 2020; 25(3):716. https://doi.org/10.3390/molecules25030716

Chicago/Turabian Style

Amariucai-Mantu, Dorina, Violeta Mangalagiu, Ramona Danac, and Ionel I. Mangalagiu. 2020. "Microwave Assisted Reactions of Azaheterocycles Formedicinal Chemistry Applications" Molecules 25, no. 3: 716. https://doi.org/10.3390/molecules25030716

Article Metrics

Back to TopTop